下一个

自动播放

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

2 意见 • 07/03/23
分享
嵌入
administrator
administrator
订户
0

Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放